Syncona Portfolio Ltd Long-Term Concentrated

CIK: 0001725042 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 4, 2022

Total Value ($000): $57,543 (100.0% shares, 0.0% debt)

Holdings (4)

— ACHILLES THERAPEUTICS PLC 43.5%

Value ($000) $25,057 Shares 11,086,909 Est. Cost $5.01 Unrealized —

AUTL AUTOLUS THERAPEUTICS PLC 27.3%

Value ($000) $15,723 Shares 7,346,829 Est. Cost $5.19 Unrealized —

— FREELINE THERAPEUTICS HLDGS 26.6%

Value ($000) $15,282 Shares 21,997,620 Est. Cost $0.50 Unrealized —

ADAPY ADAPTIMMUNE THERAPEUTICS PLC 2.6%

Value ($000) $1,481 Shares 1,377,294 Est. Cost $3.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ACHILLES THERAPEUTICS PLC	11,086,909	$25,057	43.5%	$5.01	—	SPONSORED ADS	00449L102
AUTL	AUTOLUS THERAPEUTICS PLC	7,346,829	$15,723	27.3%	$5.19	—	SPON ADS	05280R100
—	FREELINE THERAPEUTICS HLDGS	21,997,620	$15,282	26.6%	$0.50	—	SPONSORED ADS	35655L107
ADAPY	ADAPTIMMUNE THERAPEUTICS PLC	1,377,294	$1,481	2.6%	$3.75	—	SPONDS ADR	00653A107